Interleukin-17 and kidney allograft outcome.

Crispim, J C O; Grespan, R; Martelli-Palomino, G; Rassi, D M; Costa, R S; Saber, L T; Cunha, F Q; Donadi, E A

Crispim, J C O; Grespan, R; Martelli-Palomino, G; Rassi, D M; Costa, R S; Saber, L T; Cunha, F Q; Donadi, E A.

Affiliation

Crispim JC; Department of Biochemistry and Immunology, School of Medicine of Ribeirão Preto, University of São Paulo, (FMRP-USP), São Paulo, Brazil. janacrispim@usp.br

Transplant Proc ; 41(5): 1562-4, 2009 Jun.

Article in En | MEDLINE | ID: mdl-19545679

Subject(s)

Biomarkers/blood; Graft Rejection/blood; Interleukin-17/blood; Adult; Animals; Biopsy; Female; Graft Rejection/immunology; Humans; Immunosuppressive Agents/therapeutic use; Male; Mice; Middle Aged; Reference Values

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Biomarkers / Interleukin-17 / Graft Rejection Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Animals / Female / Humans / Male / Middle aged Language: En Year: 2009 Type: Article

Fulltext

XML

PubMed Links

Search on Google